Schedule
Workshop
|
Workshop 1
Moderator |
Topic Optimizing Sampling
Technique in Lung Cancer Isnu
Pradjoko, dr., Sp.P(K) |
|
|
08.00 – 08.15 |
Registrasi |
|
|
08.15 – 08.30 |
Pre Tes |
|
|
08.30 – 09.00 |
Diagnostic Methods
in Pulmonary Oncology |
Farah Fatma Wati,
dr., Sp.P(K) |
|
09.00 – 09.30 |
Optimizing
Bronchoscopy for Lung Cancer |
Dr. Isnin Anang
Marhana, dr., Sp.P(K) |
|
09.30 – 10.00 |
Ultrasound guiding
Core Biopsy for Lung Cancer |
Irmi Syafaah, dr.,
Sp.P(K) |
|
10.00 – 10.20 |
Discussion |
|
|
10.30 – 10.45 |
FOB Video
Demonstration |
|
|
10.45 – 11.00 |
USG guiding Core
Biopsy Video Demonstration |
|
|
11.00 – 11.15 |
Post Test |
|
|
Workshop
2
Moderator |
Topic Pulmonary Disorder Screening for New
Employee Recruitment Garinda Alma Duta, dr., Sp.P |
|
|
12.00 – 12.15 |
Registrasi |
|
|
12.15 – 12.30 |
Pre Test |
|
|
12.30 – 13.00 |
Benefits of lung disease
screening for new recruits |
Agus Hidayat, dr., Sp.P |
|
13.00 – 13.30 |
ILO interpretation of
Chest X-ray |
Ariani Permatasari, dr.,
Sp.P(K) |
|
13.30 – 14.00 |
Laboratory and Radiology
Diagnostic Procedure for Pulmonary Disorder |
Prastuti Asta W., dr.,
Sp.P |
|
14.00 – 14.30 |
Spirometry Interpretation |
Dwi Wahyu I., dr., Sp.P |
|
14.30 – 15.00 |
Discussion |
|
|
15.00 – 15.15 |
Post Test |
|
Sunday, 7th November 2021
|
Workshop 3
Moderator |
Topic Holistic Management for Asthma
& COPD Patient Alfian Nur R,
dr., Sp.P(K) |
|
|
08.00 – 08.15 |
Registrasi |
|
|
08.15 – 08.30 |
Pre Test |
|
|
08.30 – 09.00 |
Role of Spirometry
in COPD Management |
Dr. Daniel M.,
dr., Sp.P(K) |
|
09.00 – 09.30 |
How to Manage
Difficult to Treat Asthma |
Prof. Dr. M. Amin,
dr., Sp.P(K) |
|
09.30 – 10.00 |
Oxygen Therapy in
COPD |
Arief Bakhtiar,
dr., Sp.P(K) |
|
10.00 – 10.20 |
Pulmonary
Rehabilitation in COPD |
Helmia H., dr.,
Sp.P(K), M.Pd.Ked |
|
10.30 – 10.45 |
Discussion |
|
|
10.45 – 11.00 |
Case Discussion |
|
|
11.00 – 11.15 |
Post Test |
|
Symposium
Saturday, 13th November 2021
|
|
TOPIC |
SPEAKER |
|
07.30-07.35 |
Welcome speech by Chairman
of PKB 2021 |
Herley Windo S, dr., Sp.P |
|
07.35-07.40 |
Welcome speech by Chairman
of Department of Pulmonology and Respiratory Medicine Universitas Airlangga |
Dr. Isnin Anang M, dr.,
Sp.P (K) |
|
07.40 – 07.45 07.45 - 07.55 |
Welcome speech by Dean of
Faculty of Medicine Universitas Airlangga Indonesia Raya - Mars PDPI - Hymne Airlangga |
Prof. Dr. Budi Santoso,
dr., Sp.OG(K) |
Session I
Moderator: |
Topic Intervention and Critical Care Isnu Pradjoko, dr., Sp.P(K) |
|
|
08.00 – 08.20 |
Maximizing the use of pigtails
in patients with massive pleural effusions |
Herley Windo Setiawan, dr., Sp.P |
|
08.20 – 08.40 |
Reducing mortality in
Respiratory Failure due to ARDS |
Irmi Syafaah, dr., Sp.P(K) |
|
08.40 – 08.55 |
Discussion |
|
Session II
Moderator: |
Topic Recent Update of Targeted Therapy in
NSCLC Farah Fatma Wati, dr., Sp.P(K) |
|
|
09.00 – 09.20 |
Diagnostic Procedure in
Management of NSCLC |
Dr. Isnin Anang Marhana,
dr., Sp.P(K) |
|
09.20 –09.40 |
New Paradigm: Extending
Survival in Stage III NSCLC |
Anna Febriani, dr.,
Sp.P(K) |
|
09.40 – 10.00 |
Practice Challenges in
Advanced EGFR/Mutant NSCLC: Clarifying First Line Strategies |
Dr. Laksmi Wulandari, dr.,
Sp.P(K) |
|
10.00 – 10.15 |
Discussion |
|
Session III
Moderator: |
Topic Role of Immunotherapy for NSCLC Anna Febriani, dr., Sp.P(K) |
|
|
10.20 – 10.40 |
Pembrolizumab positioning
for NSCLC Management in monotherapy setting |
Farah Fatma Wati, dr.,
Sp.P(K) |
|
10.40 – 11.00 |
Pembrolizumab Combination
with Chemotherapy in First Line Setting for NSCLC no Driver Mutation |
Dr. Laksmi Wulandari, dr.,
Sp.P(K) |
|
11.00 – 11.15 |
Discussion |
|
Session IV
Moderator : |
Topic Managing Oxidative Stress in Pulmonary
Disease Ariani Permata Sari., dr., Sp.P(K) |
|
|
11.20 – 11.40 |
New Paradigm : Stress
Oxidative in COVID-19 and Chronic Lung Disease |
Winariani K., dr.,
Sp.P(K), MARS |
|
11.40 – 12.00 |
Optimizing Lung Protection
in COVID-19 and Chronic Lung Disease with NAC |
Wiwin Is Effendi, dr.,
Sp.P(K), Ph.D |
|
12.00 – 12.15 |
Discussion |
|
Sunday, 14th November 2021
Session V
Moderator : |
Topic Update in Management of Severe-Critical
COVID-19 Prastuti Asta, dr., Sp.P(K) |
|
|
08.00 – 08.20 |
The Role of Glutamine in
Sepsis |
Dr. Soedarsono, dr.,
Sp.P(K) |
|
08.20 – 08.40 |
Budesonide Inhalation
Therapy in COVID-19 and Post-COVID Syndrome |
Helmia Hasan, dr.,
Sp.P(K), M.Pd.Ked |
|
08.40 – 08.55 |
Discussion |
|
Session VI
Moderator: |
Topic Reducing Overused SABA in Asthmatic
Patients Dwi Wahyu I., dr., Sp.P |
|
|
09.00 – 09.20 |
The Importance High Dose
Budesonide as an Addition to Standard Therapy in Acute Exacerbation in Adult
Asthmatics |
Arief Bakhtiar, dr.,
Sp.P(K) |
|
09.20 – 09.40 |
SABA Over-reliance is a
Risk, Let’s Change Now!! |
Prof. Dr. Muh. Amin, dr.,
Sp.P(K) |
|
09.40 – 09.55 |
Discussion |
|
Session VII
Moderator : |
Topic Appropiate Management Brings Optimal
Result for COPD Arief Bakhtiar, dr., Sp.P(K) |
|
|
10.00 – 10.20 |
Improving COPD Patient’s
Quality of Life |
Dr. Daniel Maranatha,
Sp.P(K) |
|
10.20 – 10.40 |
How to Choose the
Appropriate Inhaler Device in COPD Treatment |
Alfian Nur Rosyid, dr.,
Sp.P(K) |
|
10.40 – 10.55 |
Discussion |
|
|
Session VIII |
Topic Covid 19 New Wave, Are We Ready Yet? Garindra Alma Duta, dr., Sp.P(K) |
|
|
11.00 – 11.20 |
Update on Surviving Sepsis Campaign 2021 |
Tutik Kusmiati, dr.,
Sp.P(K) |
|
11.20 – 11.40 |
Clinical Implication in
SARS-CoV-2 Mutation |
Dr. Resti Yudhawati, dr.,
Sp.P(K) |
|
11.40 – 11.55 |
Discussion |
|
|
11.55 - end |
Closing |
|